Chaman Saini Selected Research

Intravenous Immunoglobulins (IVIG)

1/2022

COVID-19: Immunology, Immunopathogenesis and Potential Therapies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chaman Saini Research Topics

Disease

13	Leprosy (Hansen's Disease) 01/2023 - 01/2013
6	Inflammation (Inflammations) 01/2022 - 04/2016
4	Lepromatous Leprosy 01/2020 - 01/2013
3	COVID-19 09/2022 - 01/2022
3	Tuberculoid Leprosy 01/2018 - 01/2013
2	Cytokine Release Syndrome 09/2022 - 01/2022
2	Disease Progression 01/2020 - 01/2017
1	Edema (Dropsy) 12/2023
1	Osteoporosis 01/2023
1	Infections 01/2022
1	Multiple Organ Failure (MODS) 01/2022
1	Cutaneous Tuberculosis (Scrofuloderma) 01/2018
1	Autoimmune Diseases (Autoimmune Disease) 04/2016
1	Erythema Nodosum 05/2013

Drug/Important Bio-Agent (IBA)

11	CytokinesIBA 12/2023 - 01/2013
11	Interleukin-17 (Interleukin 17)IBA 09/2022 - 01/2013
5	Interleukin-10 (Interleukin 10)IBA 01/2023 - 01/2017
3	AntigensIBA 04/2016 - 01/2013
2	LigandsIBA 01/2023 - 01/2017
2	interleukin-21 (interleukin 21)IBA 01/2022 - 04/2016
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 04/2016
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 05/2013
2	Interleukin-23 (Interleukin 23)IBA 01/2017 - 04/2016
1	Estrogens (Estrogen)FDA Link 01/2023
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2022
1	InterleukinsIBA 09/2022
1	VaccinesIBA 01/2022
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2022
1	Interleukin-12 (IL 12)IBA 01/2017
1	ChemokinesIBA 04/2016
1	MitogensIBA 01/2014
1	Interferon-gamma (Interferon, gamma)IBA 05/2013
1	Peptides (Polypeptides)IBA 05/2013
1	Protein Isoforms (Isoforms)IBA 01/2013
1	InterferonsIBA 01/2013
1	Interleukin-4 (Interleukin 4)IBA 01/2013

Therapy/Procedure

3	Therapeutics 09/2022 - 01/2017
1	Immunotherapy 01/2018